TRIAD

Study / Research

The first clinical trial of the Dog Aging Project, testing rapamycin's effects on healthy lifespan in pet dogs, aiming to detect a 15% change in lifespan within a three-year window.

Mentioned in 1 video

Videos Mentioning TRIAD

175 - The biology of aging, rapamycin, and other interventions that target the aging process

175 - The biology of aging, rapamycin, and other interventions that target the aging process

Peter Attia MD

The first clinical trial of the Dog Aging Project, testing rapamycin's effects on healthy lifespan in pet dogs, aiming to detect a 15% change in lifespan within a three-year window.